Background: The aim of this descriptive study was the comparison of the clinical and surgical data of patients who suffered from cavernoma and were treated surgically with and without intraoperative navigation (ultrasound, neuronavigation).

Method: Between 1995 and 2002, 40 patients were treated for cavernous malformations microsurgically: 24 patients (group I) using a neuronavigation system (STP 4.0, SNN, Germany), 7 patients (group II) using ultrasound (Siemens Omnia with 5.0 MHz Probe) and 9 patients (group III) without any image guidance using anatomic landmarks.

Findings: With the use of neuronavigation the mean sizes of cavernous malformations, which were resected, were reduced from 25.6 mm (group III) and 24.4 mm (group II) to 16.3 mm (group I) (p > or = 0.05). Corresponding to the reduction of the cavernoma size, the mean distances of the vascular lesion to the cortical surface increased from 13.9 mm (group III) and 17.8 mm (group II) to 24.4 mm under neuronavigational support (p > or = 0.05). All cavernomas were resected completely in all 40 patients. Postoperative neuroradiological control (MRI) confirmed complete resection in all cases. No significant differences in the clinical outcome could be evaluated in all three groups up to three months postoperatively.

Conclusions: Use of neuronavigation was associated with a more comfortable and safer surgery of smaller and more deeper-seated cavernomas. In spite of the lack of significance between all groups, the advantages of neuronavigation in planning and realising surgery could be documented, which justify the additional costs and time-consuming acquisition of planning image data and postprocessing as well as intraoperative navigation.

Download full-text PDF

Source
http://dx.doi.org/10.1055/s-2005-919163DOI Listing

Publication Analysis

Top Keywords

cavernous malformations
12
patients group
12
group iii
12
intraoperative navigation
8
group
8
patients
6
surgery cavernous
4
malformations navigational
4
navigational support--a
4
support--a comparative
4

Similar Publications

Increases in mean lesional iron content by quantitative susceptibility mapping (QSM) by ≥6% and/or vascular permeability by dynamic contrast enhanced quantitative perfusion (DCEQP) by ≥40% on MRI have been associated with new symptomatic hemorrhage (SH) in cerebral cavernous malformations (CCMs). It is not known if plasma biomarkers can reflect these changes within the lesion proper. This cohort study enrolled 46 CCM patients with SH in the prior year.

View Article and Find Full Text PDF

To evaluate the incidence of mortality, hemorrhage, and neurological deficits in treating intracranial arteriovenous malformations (AVMs) in patients over 18 through a comparative analysis of surgical approaches and other therapeutic modalities. A systematic review was conducted using MEDLINE, Embase, CENTRAL, and LILACS databases in November 2023. Inclusion criteria included clinical trials, cohorts studies, case-controls studies, and case series comparing patients over 18 undergoing surgery or microsurgery versus other treatments (radiosurgery, isolated embolization, and conservative treatment).

View Article and Find Full Text PDF

Objective: To evaluate iron deposition patterns in patients with cerebral cavernous malformation-related epilepsy (CRE) using quantitative susceptibility mapping (QSM) for detailed analysis of iron distribution associated with a history of epilepsy and severity.

Methods: This study is part of the Quantitative Susceptibility Biomarker and Brain Structural Property for Cerebral Cavernous Malformation Related Epilepsy (CRESS) cohort, a prospective multicenter study. QSM was used to quantify iron deposition in patients with sporadic cerebral cavernous malformation (CCMs).

View Article and Find Full Text PDF

Endothelial-mesenchymal transition (EndMT) is defined as an important process of cellular differentiation by which endothelial cells (ECs) are prone to lose their characteristics and transform into mesenchymal cells. During EndMT, reduced expression of endothelial adhesion molecules disrupts intercellular adhesion, triggering cytoskeletal reorganization and mesenchymal transition. Numerous studies have proved that EndMT is a multifaceted biological event driven primarily by cytokines such as TGF-β, TNF-α, and IL-1β, alongside signaling pathways like WNT, Smad, MEK-ERK, and Notch.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!